Healthcare & Biotech

Delray Beach, Fla. – – September 15, 2026 -- The global High Flow Nasal Cannula (HFNC) market is projected to grow from USD 0.94 billion in 2026 to USD 1.44 billion by 2031, a compound annual growth rate of 8.9%, according to MarketsandMarkets.

North America leads a market shifting toward recurring consumables revenue

North America held the largest regional share of the HFNC market in 2025, supported by advanced critical-care infrastructure and established manufacturers. By product, consumables and accessories outpaced systems in market share, while adults represented the largest patient-type segment. Acute respiratory failure treatment led application demand, and hospitals remained the dominant end-user category due to intensive care unit and emergency department volumes.

Fremont, Calif. – September 15, 2026 -- Q'Apel Medical has launched the Lynx Aspiration Catheter System in the United States, expanding its neurovascular portfolio into the aspiration category for mechanical thrombectomy, the standard of care for acute ischemic stroke caused by vessel occlusion.

Lynx becomes the second Q'Apel product built on proprietary QLCT technology

The Lynx system marks the second device to feature Q'Apel's proprietary Q'Apel Laser Cut Tube (QLCT) technology, following the company's earlier product on this engineering platform. The catheters use a bimetal shaft design with an open-spaced nitinol structure intended to balance proximal support with distal flexibility while resisting kinking during navigation through complex cerebrovascular anatomy.

Quebec City – September 15, 2026 -- Icentia has appointed Sanjay Voleti as President and CEO, tasking the digital health veteran with accelerating the cardiac diagnostics company's commercial expansion in the United States.

Voleti succeeds co-founder Pierre Paquet after the company built operations across four countries

Voleti replaces co-founder Pierre Paquet, who led Icentia from its founding as a Canadian health-tech startup into an international operator with a presence in Canada, the United Kingdom, Ireland and the United States. Paquet said the company's CardioSTAT platform has become a reference point in continuous ambulatory ECG recording and that the time had come to bring in a leader experienced in scaling technology companies internationally.

New York – September 15, 2026 -- AEYE Health published peer-reviewed results in Frontiers in Digital Health confirming its FDA-cleared AEYE-DS system achieved over 99% imageability across three prospective, controlled pivotal trials involving more than 1,200 diabetic patients.

Trial data validate the clinical foundation behind AEYE-DS's two FDA clearances

The study, covering trials AEYE-1, AEYE-2 and AEYE-3, benchmarked the autonomous AI against reading center multi-expert clinical review. AEYE-DS requires only a single image per eye, works with both portable handheld and tabletop cameras, and rarely requires pupil dilation -- making it the only FDA-cleared portable autonomous solution for diabetic retinopathy on the market, according to the company.

New York – September 13, 2026 -- BRG has appointed Jamie LaGuardia-Frie as managing director in its Healthcare practice, tasking her with leading business development and client strategy for the firm's Healthcare Advisory team.

LaGuardia-Frie brings more than 20 years of healthcare consulting and technology experience

Based in New York, she joins after serving as managing director and chief commercial officer for Alvarez & Marsal's Health Industry Group. She spent nearly a decade at Guidehouse, holding roles including Health Growth Leader and East Regional Market Leader for Commercial Healthcare. Earlier in her career, she worked in consulting, business development and technology at Accretive Health and Allscripts.

Louisville, Ky. – September 13, 2026 -- Induction Therapies and Collagen P.I.N., in partnership with aesthetic physician Dr. Shino Bay Aguilera, released new clinical findings on a treatment protocol combining Collagen P.I.N. microneedling with PRX8, a plant-derived exosome serum, for melasma in a patient with Fitzpatrick skin type V.

Patient shows sustained improvement after four treatments over eight weeks

The case involved a woman with longstanding facial melasma who had previously used topical hydroquinone and tranexamic acid without full resolution. She underwent four Collagen P.I.N. treatments over an eight-week period, with TRUExosomes PRX8 Plant-Exo Stimulation Serum applied after each session and daily sunscreen maintained throughout.

Visible improvement in the appearance of melasma was observed across the treatment course and persisted at the two-week follow-up after the final treatment, with no adverse reactions reported.

Montreal – September 13, 2026 -- Onix, the Montreal-based startup behind what it calls Personal Intelligence, has closed $5 million USD (roughly $7 million CAD) in pre-seed funding led by Los Angeles-based Alpha Edison, with participation from Garage Capital, Ride Home Fund, and strategic backers Jeremy Zimmer, co-founder of UTA, and JS Cournoyer, co-founder of Real Ventures.

Round size dwarfs typical Canadian pre-seed deals

According to the Canadian Venture Capital and Private Equity Association, the raise is more than seven times the average Canadian pre-seed deal recorded in 2025 and exceeds the average Canadian seed round. U.S. investor participation in Canadian pre-seed deals fell from 23% in 2024 to 8% in 2025, making Alpha Edison's lead investment in a Canadian company a departure from that broader retreat.

Kirkland – September 13, 2026 -- MacroHealth, a marketplace platform connecting healthcare payers and plan administrators with vendor partners, has appointed Erica Tingley as Chief Financial Officer to oversee financial and operational scaling as the company expands its service categories.

Tingley brings 25 years of healthcare finance experience to the CFO role

Tingley's background spans investment banking, mergers and acquisitions, corporate finance and operations. She most recently served as President and CFO of Knowtion Health, a revenue cycle management partner to health systems, where she managed both financial strategy and solution delivery. Before that role, she was COO and CFO of Bluesight, where she worked on driving consistent, profitable growth. Earlier in her career, she held positions at The Advisory Board Company and Bank of America Merrill Lynch.

Berlin – September 13, 2026 -- Germany's largest doctors' association, the Marburger Bund, has warned lawmakers that a draft reform of emergency medical care could hand health insurers de facto control over which local emergency sites survive, ahead of a public hearing before the Bundestag's Health Committee.

Marburger Bund backs the goal of linking outpatient and inpatient emergency care but flags flaws in the bill

Dr. Susanne Johna, chairwoman of the Marburger Bund, told the committee that better integration of ambulatory and hospital-based emergency structures is needed so patients reach the appropriate care point reliably. She cautioned, however, that the current draft contains provisions that could create new operational problems in practice.

Rocky River, Ohio – September 13, 2026 -- Roundstone Insurance will hold its annual Medical Captive Forum (MCF) on May 11 and 12, 2027, in Nashville, Tennessee, bringing together hundreds of employer executives to tackle rising health plan costs.

Event targets employers moving away from fully insured health models

The complimentary two-day forum will gather CEOs, CFOs, HR leaders, benefits advisors, and healthcare innovators to discuss redesigning health plans for greater transparency, cost control, and long-term sustainability. Sessions will cover plan design, captive insurance structures, and cost containment strategies through panels, roundtables, and networking.

Roundstone reimburses attendees for lodging costs

Beyond complimentary programming, Roundstone will reimburse employers for one night's hotel stay, lowering the barrier for mid-market companies to attend.